Tilray Medical Launches its First Commercial “Grown in Germany” Medical Cannabis Products Under its Newly Expanded Cultivation License
November 14, 2024 07:00 ET
|
Tilray Brands, Inc.
Tilray Medical announced the launch of its first commercial German grown medical cannabis flowers from its Aphria RX GmbH (“Aphria RX”) facility.
Tilray Medical Announces Positive Results from Study on Oral Cannabis Extract for Chemotherapy-Induced Emesis
November 07, 2024 07:00 ET
|
Tilray Brands, Inc.
This trial aimed to test the effectiveness of an oral cannabis extract in adults suffering from negative chemotherapy-induced side effects.
Tilray Brands Launches Charlotte’s Web™ CBD Gummies in Canada
October 07, 2024 07:00 ET
|
Tilray Brands, Inc.
TORONTO, Oct. 07, 2024 (GLOBE NEWSWIRE) -- Tilray Brands, Inc. ("Tilray") (Nasdaq: TLRY; TSX: TLRY), a global lifestyle and consumer packaged goods company, announced the launch of new Charlotte's...
Tilray Medical Launches Redecan Cannabis Brand in Australia
September 18, 2024 07:00 ET
|
Tilray Brands, Inc.
Tilray's EU-GMP Certified Redecan Cannabis Now Available in Australia with Medical Prescription.
Tilray Medical Supports Scientific Study on Fibromyalgia With Positive Outcomes: Effectiveness of Cannabinoids Treatment in Pain Management and Other Fibromyalgia-Associated Symptoms
September 09, 2024 07:00 ET
|
Tilray Brands, Inc.
LISBON, Portugal, Sept. 09, 2024 (GLOBE NEWSWIRE) -- Tilray Medical, a division of Tilray Brands, Inc. (“Tilray”) (Nasdaq: TLRY; TSX: TLRY) and a global leader in medical cannabis, empowering the...
Tilray Medical Announces Scientific Study on Medical Cannabis for Patients Over Age 50
July 09, 2024 07:00 ET
|
Tilray Brands, Inc.
Tilray-led scientific publication examines the real-world impact of medical cannabis use on patients over the age of 50.
Tilray Medical Announces New Scientific Publication on Age-Related Patterns of Medical Cannabis Use
April 03, 2024 07:00 ET
|
Tilray Brands, Inc.
Tilray Medical announced a new Tilray led scientific publication, Age-related Patterns of medical Cannabis Use: A Survey of Authorized Patients in Canada.
Tilray Medical Receives Approval for First Medical Cannabis Extract in Portugal
March 14, 2024 07:00 ET
|
Tilray Brands, Inc.
Tilray Medical has received approval for the first medical cannabis extract, Tilray Oral Solution THC 5 CBD 20, in Portugal.
Tilray Provides International Cannabis Update on Milestone German Cannabis Legalization
February 28, 2024 07:00 ET
|
Tilray Brands, Inc.
Tilray is bullish on the positive paradigm shift that the new German drug policy creates for the future of cannabis in Europe.
Tilray Medical Applauds German Bundestag and Landmark Passage of Medical Cannabis Act in Germany
February 23, 2024 10:38 ET
|
Tilray Brands, Inc.
Tilray Medical welcomes the opening of the German medical cannabis market and the positive paradigm shift in German drug policy.